Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherene Loi

Showing results (31-40 of 325) with videos related to

Pageof 33
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2022
Challenges of Creating New Tumor-Infiltrating Lymphocyte for Combating Breast CancerPaul A Beavis, Emily B Derrick, Sherene Loi
Current Opinion in Oncology|January 1, 2005
Challenges in breast cancer clinical trial design in the postgenomic eraSherene Loi, Marc Buyse, Christos Sotiriou, et al.
Cancer Immunology Research|June 2, 2023
Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic StatusAlice R T Bergin, Roberto Salgado, Sherene Loi
Nature Medicine|February 12, 2021
Intratumoral heterogeneity in cancer progression and response to immunotherapyIlio Vitale, Efrat Shema, Sherene Loi, et al.
Nephrology (Carlton, Vic.)|January 25, 2005
Glomerulosclerosis: a paraneoplastic phenomenon?Sherene Loi, Gregory J Perry, Hugo Standish, et al.
Oncotargets and Therapy|May 10, 2011
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selectionCarmen Criscitiello, Debora Fumagalli, Kamal S Saini, et al.
Current Opinion in Oncology|September 5, 2014
Oncogene addiction and immunity: clinical implications of tumour infiltrating lymphocytes in breast cancers overexpressing the HER2/neu oncogenePeter Savas, Franco Caramia, Zhi Ling Teo, et al.
Advances in Immunology|March 1, 2016
Mouse Models of Tumor ImmunotherapyShin Foong Ngiow, Sherene Loi, David Thomas, et al.
Current Treatment Options in Oncology|May 24, 2017
Advancing Immunotherapy in Metastatic Breast CancerMariam Mansour, Zhi Ling Teo, Stephen J Luen, et al.
Nature Reviews. Clinical Oncology|February 3, 2026
Tailoring targeted therapies for younger women with ER-positive early-stage breast cancerSoraia Lobo-Martins, Stephen J Luen, Martine Piccart, et al.
Pageof 33

Showing results (31-40 of 325) with videos related to

Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2022
Challenges of Creating New Tumor-Infiltrating Lymphocyte for Combating Breast CancerPaul A Beavis, Emily B Derrick, Sherene Loi
Current Opinion in Oncology|January 1, 2005
Challenges in breast cancer clinical trial design in the postgenomic eraSherene Loi, Marc Buyse, Christos Sotiriou, et al.
Cancer Immunology Research|June 2, 2023
Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic StatusAlice R T Bergin, Roberto Salgado, Sherene Loi
Nature Medicine|February 12, 2021
Intratumoral heterogeneity in cancer progression and response to immunotherapyIlio Vitale, Efrat Shema, Sherene Loi, et al.
Nephrology (Carlton, Vic.)|January 25, 2005
Glomerulosclerosis: a paraneoplastic phenomenon?Sherene Loi, Gregory J Perry, Hugo Standish, et al.
Oncotargets and Therapy|May 10, 2011
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selectionCarmen Criscitiello, Debora Fumagalli, Kamal S Saini, et al.
Current Opinion in Oncology|September 5, 2014
Oncogene addiction and immunity: clinical implications of tumour infiltrating lymphocytes in breast cancers overexpressing the HER2/neu oncogenePeter Savas, Franco Caramia, Zhi Ling Teo, et al.
Advances in Immunology|March 1, 2016
Mouse Models of Tumor ImmunotherapyShin Foong Ngiow, Sherene Loi, David Thomas, et al.
Current Treatment Options in Oncology|May 24, 2017
Advancing Immunotherapy in Metastatic Breast CancerMariam Mansour, Zhi Ling Teo, Stephen J Luen, et al.
Nature Reviews. Clinical Oncology|February 3, 2026
Tailoring targeted therapies for younger women with ER-positive early-stage breast cancerSoraia Lobo-Martins, Stephen J Luen, Martine Piccart, et al.
Pageof 33